Achilles Therapeutics Pl-adr logo

Achilles Therapeutics Pl-adr share price today

(ACHL)

Achilles Therapeutics Pl-adr share price is $1.14 & ₹97.13 as on 25 Dec 2024, 2.30 'hrs' IST

$1.14

0.16

(16.18%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Achilles Therapeutics Pl-adr share price in Dollar and Rupees. Guide to invest in Achilles Therapeutics Pl-adr from India. Also see the sentimental analysis on Indian investors investing in Achilles Therapeutics Pl-adr. Get details on the Indian mutual funds that are investing in Achilles Therapeutics Pl-adr. Get Analyst recommendations and forecasts along with all the Achilles Therapeutics Pl-adr's financials.

Achilles Therapeutics Pl-adr share price movements

  • Today's Low: $0.98
    Today's High: $1.17

    Day's Volatility :16.57%

  • 52 Weeks Low: $0.63
    52 Weeks High: $1.76

    52 Weeks Volatility :64.2%

Achilles Therapeutics Pl-adr Returns

PeriodAchilles Therapeutics Pl-adrSector (Health Care)Index (Russel 2000)
3 Months
16.08%
-8.7%
0.0%
6 Months
40.74%
-5.0%
0.0%
1 Year
32.04%
3.2%
0.0%
3 Years
-78.49%
0.0%
-21.1%

Achilles Therapeutics Pl-adr Key Statistics

in dollars & INR

Previous Close
$0.9812
Open
$0.9855
Today's High
$1.17
Today's Low
$0.9761
Market Capitalization
$41.9M
Today's Volume
$2.2M
52 Week High
$1.76
52 Week Low
$0.63
Revenue TTM
$0.0
EBITDA
$-65.9M
Earnings Per Share (EPS)
$-1.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-44.22%

How to invest in Achilles Therapeutics Pl-adr from India?

It is very easy for Indian residents to invest directly in Achilles Therapeutics Pl-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Achilles Therapeutics Pl-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Achilles Therapeutics Pl-adr or ACHL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Achilles Therapeutics Pl-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Achilles Therapeutics Pl-adr shares which would translate to 0.747 fractional shares of Achilles Therapeutics Pl-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Achilles Therapeutics Pl-adr, in just a few clicks!

Returns in Achilles Therapeutics Pl-adr for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Achilles Therapeutics Pl-adr investment value today

Current value as on today

₹1,34,984

Returns

₹34,984

(+34.98%)

Returns from Achilles Therapeutics Pl-adr Stock

₹32,558 (+32.56%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Achilles Therapeutics Pl-adr

-5%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Achilles Therapeutics Pl-adr on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -5% less investors are searching Achilles Therapeutics Pl-adr in the last 30 days versus the previous period.

Global Institutional Holdings in Achilles Therapeutics Pl-adr

  • Syncona Portfolio Ltd.

    26.98%

  • BML Capital Management LLC

    9.98%

  • FCPM III SERVICES BV

    5.82%

  • Redmile Group, LLC

    3.91%

  • Vestal Point Capital LP

    3.65%

  • Ikarian Capital, LLC

    3.51%

Analyst Recommendation on Achilles Therapeutics Pl-adr

Buy

    70%Buy

    20%Hold

    10%Sell

Based on 10 Wall street analysts offering stock ratings for Achilles Therapeutics Pl-adr(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
8
Hold
2
1
1
Sell
1
1
1

Analyst Forecast on Achilles Therapeutics Pl-adr

What analysts predicted

Upside of 426.32%

Current:

$1.14

Target:

$6.00

Insights on Achilles Therapeutics Pl-adr

  • Price Movement

    In the last 7 days, ACHL stock has moved up by 18.1%
  • ACHL vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 104.7%

Achilles Therapeutics Pl-adr Technicals Summary

Sell

Neutral

Buy

Achilles Therapeutics Pl-adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Achilles Therapeutics Pl-adr Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Achilles Therapeutics Pl-adr
6.54%
40.74%
32.04%
-78.49%
-83.97%
Regeneron Pharmaceuticals, Inc.
-4.68%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-5.49%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.08%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-11.59%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Achilles Therapeutics Pl-adr
0.17
NA
NA
0.0
-0.44
-0.27
NA
3.47
Regeneron Pharmaceuticals, Inc.
17.7
17.7
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Achilles Therapeutics Pl-adr
Buy
$41.9M
-83.97%
0.17
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.6B
91.19%
17.7
33.61%
Biontech Se
Buy
$27.2B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.2B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$104.4B
86.41%
32.84
-4.51%

About Achilles Therapeutics Pl-adr

achilles therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells. the therapies will target truncal (also known as clonal) tumour neo-antigens, unique flags to the immune system present on the surface of every cancer cell. these truncal neo-antigens are created early in the cancer’s evolution and present on all cancer cells in an individual patient’s tumour but not on healthy cells, so could allow scientists to target and destroy tumours without harming healthy tissues. achilles therapeutics brings together four scientific founders with world leading expertise in the understanding of cancer evolution, bioinformatics and the development of immunotherapies.
Organization
Achilles Therapeutics Pl-adr
Employees
204
CEO
Dr. Iraj Ali Ph.D.
Industry
Healthcare

Management People of Achilles Therapeutics Pl-adr

NameTitle
Dr. Iraj Ali Ph.D.
CEO & Director
Dr. Sergio A. Quezada Ph.D.
Founder & Chief Scientific Officer
Mr. Robert Coutts
Chief Financial Officer
Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Charles Swanton FMEDSCI, M.D., Ph.D.
Founder & Member of Scientific Advisory Board
Mr. Lee M. Stern
Vice President of Investor Relations & External Communications
Mr. Daniel Carey Cazel Hood
General Counsel & Company Secretary
Julia Wilson
Head of Communications
Mr. Tariq Ahmed
Executive Vice President of People
Mr. Edward Samuel
Executive Vice President of Technical Operations

Important FAQs about investing in Achilles Therapeutics Pl-adr from India :

What is Achilles Therapeutics Pl-adr share price today?

Achilles Therapeutics Pl-adr share price today stands at $1.14, Open: $0.99 ; Previous Close: $0.98 ; High: $1.17 ; Low: $0.98 ; 52 Week High: $1.76 ; 52 Week Low: $0.63. The stock opens at $0.99, after a previous close of $0.98. The stock reached a daily high of $1.17 and a low of $0.98, with a 52-week high of $1.76 and a 52-week low of $0.63.

Can Indians buy Achilles Therapeutics Pl-adr shares?

Yes, Indians can invest in the Achilles Therapeutics Pl-adr (ACHL) from India.

With INDmoney, you can buy Achilles Therapeutics Pl-adr at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Achilles Therapeutics Pl-adr at zero transaction cost.

How can I buy Achilles Therapeutics Pl-adr shares from India?

It is very easy to buy Achilles Therapeutics Pl-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Achilles Therapeutics Pl-adr be purchased?

Yes, you can buy fractional shares of Achilles Therapeutics Pl-adr with INDmoney app.

What are the documents required to start investing in Achilles Therapeutics Pl-adr stocks?

To start investing in Achilles Therapeutics Pl-adr, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Achilles Therapeutics Pl-adr

Today’s highest price of Achilles Therapeutics Pl-adr (ACHL) is $1.17.

Today’s lowest price of Achilles Therapeutics Pl-adr (ACHL) is $0.98.

What is today's market capitalisation of Achilles Therapeutics Pl-adr

Today's market capitalisation of Achilles Therapeutics Pl-adr ACHL is 41.9M

What is the 52 Week High and Low Range of Achilles Therapeutics Pl-adr

  • 52 Week High

    $1.76

  • 52 Week Low

    $0.63

What are the historical returns of Achilles Therapeutics Pl-adr?

  • 1 Month Returns

    6.54%

  • 3 Months Returns

    40.74%

  • 1 Year Returns

    32.04%

  • 5 Years Returns

    -83.97%

Who is the Chief Executive Officer (CEO) of Achilles Therapeutics Pl-adr

Dr. Iraj Ali Ph.D. is the current Chief Executive Officer (CEO) of Achilles Therapeutics Pl-adr.